Rubicon Organics Inc. (ROMJ.V)

CAD 0.4

(-1.25%)

Total Debt Summary of Rubicon Organics Inc.

  • Rubicon Organics Inc.'s latest annual total debt in 2023 was 10.25 Million CAD , up 1.8% from previous year.
  • Rubicon Organics Inc.'s latest quarterly total debt in 2024 Q1 was 10.79 Million CAD , up 3.78% from previous quarter.
  • Rubicon Organics Inc. reported annual total debt of 10.21 Million CAD in 2022, up 4.1% from previous year.
  • Rubicon Organics Inc. reported annual total debt of 9.81 Million CAD in 2021, down -29.81% from previous year.
  • Rubicon Organics Inc. reported quarterly total debt of 10.79 Million CAD for 2024 Q1, up 3.78% from previous quarter.
  • Rubicon Organics Inc. reported quarterly total debt of 10.76 Million CAD for 2023 Q3, up 4.64% from previous quarter.

Annual Total Debt Chart of Rubicon Organics Inc. (2023 - 2016)

Historical Annual Total Debt of Rubicon Organics Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 10.25 Million CAD 1.8%
2022 10.21 Million CAD 4.1%
2021 9.81 Million CAD -29.81%
2020 13.98 Million CAD 5.29%
2019 13.28 Million CAD 295.03%
2018 3.36 Million CAD 7.25%
2017 3.13 Million CAD 1589.93%
2016 185.51 Thousand CAD 0.0%

Peer Total Debt Comparison of Rubicon Organics Inc.

Name Total Debt Total Debt Difference
Aequus Pharmaceuticals Inc. 5.06 Million CAD -102.607%
CanadaBis Capital Inc. 7.3 Million CAD -40.363%
Decibel Cannabis Company Inc. 40.96 Million CAD 74.955%
Delivra Health Brands Inc. 2.02 Million CAD -406.145%
Entourage Health Corp. 161.58 Million CAD 93.651%
Lifeist Wellness Inc. 1.26 Million CAD -710.382%
Cannara Biotech Inc. 45.78 Million CAD 77.591%
Medicure Inc. 544 Thousand CAD -1785.949%
PharmaCielo Ltd. 18.3 Million CAD 43.963%
BioSyent Inc. 1.22 Million CAD -740.228%
Voyageur Pharmaceuticals Ltd. 40 Thousand CAD -25548.905%